enfr

SCN’s vision is to capitalize upon Canada’s competitive advantage in stem cells for the benefit of Canadians.

Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning.

In just over 17 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace. SCN has invested $100M in innovative translational research, training and outreach. This strategic funding has benefitted approximately 170 world-class research groups and 2,500 trainees from across Canada.  SCN has also catalyzed 18 clinical trials and 17 startup biotechnology companies. Its investigators have leveraged upwards of $100M in partner contributions while SCN has incubated several international and Canadian research networks and organizations.

2,500

Trainees

170

Research Groups

$100M

In Research, Training and Outreach

$100M

In Partner Support

Upcoming workshops

Learn more about travel awards and bursaries for professional development courses and workshops.

Till & McCulloch Meetings

 

In the news

Ottawa hosts Canada’s leading regenerative medicine researchers

November 12, 2018 (OTTAWA, ON) – Stem cell advances, clinical innovation and the “right to try” will top the agenda over the next three days as leading Canadian and international stem cell and regenerative medicine researchers convene in Ottawa for the Till & McCulloch Meetings. Nearly 500 scientists, post-graduate students, industry experts, policy and legal …

Read more